Notably, in those with a personal or family history of medullary thyroid carcinoma, GLP-1 medications are contraindicated, due to the theoretical risk for medullary thyroid cancer (which has not been proven in human subjects) [9]. The gene discussed is GLP1R; the disease is medullary thyroid gland carcinoma.